Clinical Trials
3 trialsNCT06360354 2026-06-01
MTAPESTRY 103
Amgen
Phase 1 Active not recruiting
NCT03530397 2026-05-19
A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors
MedImmune LLC
Phase 1 Active not recruiting
NCT03893955 2025-08-12
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
AbbVie
Phase 1 Active not recruiting